P Wordsworth

5.7k citations

91 papers · 3.5k indexed · 1 hit paper · h-index 32

Rheumatology top 0.2%
Immunology top 1%
Hematology top 2%
Molecular Biology
Radiology, Nuclear Medicine and Imaging top 5%

Co-authors: Jane Worthington Matthew A. Brown Anne Barton James Bell Stephen Eyre Andrei Călin Emma L. Duncan Chris Darke
Topics: Rheumatoid Arthritis Research and Therapies (36 papers)Systemic Lupus Erythematosus Research (26 papers)Spondyloarthritis Studies and Treatments (24 papers)
Cited by: Rheumatology Immunology Hematology
Journals: Proceedings of the National Academy of Sciences Circulation Nature Genetics
Partner nations: United Kingdom India United States

In The Last Decade

P Wordsworth

88 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Susceptibility to ankylosing spondylitis in twins the role of genes, HLA, and the environment

1997 460 citations Matthew A. Brown, Alex J. MacGregor et al. profile →

Peers

Countries citing papers authored by P Wordsworth

Since Specialization

Citations

This map shows the geographic impact of P Wordsworth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Wordsworth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Wordsworth more than expected).

Fields of papers citing papers by P Wordsworth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Wordsworth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Wordsworth. The network helps show where P Wordsworth may publish in the future.

Co-authorship network of co-authors of P Wordsworth

This figure shows the co-authorship network connecting the top 25 collaborators of P Wordsworth. A scholar is included among the top collaborators of P Wordsworth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Wordsworth. P Wordsworth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ankylosing Spondylitis Is Associated with an Increased Risk of Osteoporotic Fractures: A Population-Based Cohort Study 2012 ·Oxford University Research Archive (ORA) (University of Oxford) ·(unknown),Peter Vestergaard,Jordi Blanch,P Wordsworth,Andrew Judge,M K Javaid,N K Arden,C Cooper,Adolfo Díez‐Pérez,Daniel Prieto‐Alhambra	1
2	Improvement in Signs and Symptoms of Active Ankylosing Spondylitis Following Treatment with Anti-Interleukin (IL)-17A Monoclonal Antibody Secukinumab Are Paralleled by Reductions in Acute Phase Markers and Inflammatory Markers S100A8 and A9 (Calgranulin A and B) 2012 ·Data Archiving and Networked Services (DANS) ·(unknown),Stephan Bek,(unknown),Arndt Brachat,J. Sieper,Paul Emery,Jürgen Braun,D. van der Heijde,Iain B. McInnes,Jacob M. van Laar,Robert Landewé,P Wordsworth,J. Wollenhaupt,(unknown),(unknown),(unknown),A. Wright,(unknown)	2
3	Long Term Inhibition of Interleukin (IL)-17A with Secukinumab Improves Clinical Symptoms and Reduces Spinal Inflammation As Assessed by Magnetic Resonance Imaging in Patients with Ankylosing Spondylitis. 2012 ·Data Archiving and Networked Services (DANS) ·Xenofon Baraliakos,Jerry Braun,Didier Laurent,Dominique Baeten,D. van der Heijde,J. Sieper,Paul Emery,Iain B. McInnes,Jacob M. van Laar,Robert Landewé,P Wordsworth,J. Wollenhaupt,(unknown),A. Wright,(unknown),(unknown),B. Borah,(unknown)	4
4	GOLIMUMAB, A HUMAN TNF-ALPHA mu ONOCLONAL ANTIBODY, IN RHEUMATOID ARTHRITIS PATIENTS PREVIOUSLY TREATED WITH ANTI-TNF-ALPHA AGENTS (GO-AFTER STUDY) 2009 ·Lara D. Veeken ·P Wordsworth,Josef S Smolen,(unknown),Mittie K. Doyle,Robert Landewé,Eric L. Matteson,(unknown),E. C. Hsia,(unknown),(unknown)	1
5	Maintenance of reduction in disease activity and partial remission in patients with Ankylosing spondylitis (AS) - 3-year results from the adalimumab (HUMIRO) trial evaluating long-term efficacy and safety in AS (ATLAS) 2008 ·Oxford University Research Archive (ORA) (University of Oxford) ·Désirée van der Heijde,Ben A. C. Dijkmans,(unknown),A. Kivitz,Kurt De Vlam,P Wordsworth,Shaila Ballal,H. Küpper,(unknown),J. Sieper,(unknown)	2
6	Remission and major clinical response in active rheumatoid arthritis (RA) patients after adalimumab (Humira (R)) treatment 2007 ·Lara D. Veeken ·(unknown),P Wordsworth,Frank McKenna,(unknown),(unknown),S. Kary,H. Küpper	1
7	Clinical and experimental pain processing in rheumatoid arthritis patients treated with anti-TNF 2007 ·Lara D. Veeken ·K Wartolowska,Petra Schweinhardt,P Wordsworth,B.A. Chizh,C. Bountra,Iain P. Chessell,Irene Tracey	1
8	Il-23r is a major determinant of ankylosing spondylitis risk - The tasc study 2007 ·Annals of the Rheumatic Diseases ·John D. Reveille,(unknown),L Bradbury,(unknown),John C. Davis,Panos Deloukas,David M. Evans,Andrew Keniry,Ralph McGinnis,J J Pointon,(unknown),M H Weisman,P Wordsworth,Matthew A. Brown	7
9	Adalimumab improves physical functioning and work productivity in ankylosing spondylitis (AS) patients: Results from ATLAS. 2006 ·Oxford University Research Archive (ORA) (University of Oxford) ·Désirée van der Heijde,(unknown),P Wordsworth,Philip J. Mease,John D. Reveille,H. Zeidler,(unknown),René Westhovens,(unknown),(unknown),(unknown),John M. Davis	1
10	Analysis of positional candidate genes in ankylosing spondylitis: A possible role for ENPP1 2006 ·Lara D. Veeken ·J J Pointon,Andrew E. Timms,L Bradbury,Matthew A. Brown,P Wordsworth	1
11	Treatment with adalimumab reduces signs and symptoms and induces partial remission in patients with ankylosing spondylitis (AS): 1-year results from ATLAS. 2006 ·Oxford University Research Archive (ORA) (University of Oxford) ·Désirée van der Heijde,A. Kivitz,Michael Schiff,J. Sieper,(unknown),Jürgen Braun,Maxime Dougados,P Wordsworth,(unknown),H. Küpper,John W. Davis	4
12	Adalimumab improves health-related quality of life in patients with active ankylosing spondylitis - The ATLAS trial. 2005 ·Oxford University Research Archive (ORA) (University of Oxford) ·D. van der Heijde,Michelle Luo,A K Matsumoto,(unknown),(unknown),P Wordsworth,(unknown),John W. Davis,(unknown)	4
13	Efficacy and safety of adalimumab (Humira (R)) in European clinical practice: The ReAct trial 2005 ·Lara D. Veeken ·G. R. Burmester,P Wordsworth,Xavier Mariette,(unknown),(unknown),(unknown),H. Küpper	0
14	Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom (vol 46,pg 632, 2002) 2002 ·Queensland's institutional digital repository (The University of Queensland) ·(unknown),Stephen Eyre,Anne Myerscough,(unknown),Anne Barton,Steven H. Laval,Jeff Barrett,(unknown),S. White,Sujit John,M. J. Brown,Joseph Martin Bell,A J Silman,W E Ollier,P Wordsworth,Jane Worthington	15
15	The association of INOS promoter haplotypes with rheumatoid arthritis 2001 ·Lara D. Veeken ·Julia L. Newton,Kirk Rockett,David Burgner,Matthew A. Brown,P Wordsworth,Dominic Kwiatkowski	1
16	Confirmation of non-MHC genetic loci by whole genome linkage studies in ankylosing spondylitis. 2000 ·Queensland's institutional digital repository (The University of Queensland) ·Matthew A. Brown,S.H. Laval,Andrew E. Timms,L Bradbury,Steve Edwards,Laurence A. Rubin,Katherine Siminovitch,Andrei Călin,P Wordsworth	1
17	The role of IL-10 in rheumatoid arthritis (RA) in two ethnically diverse populations. 1999 ·Oxford University Research Archive (ORA) (University of Oxford) ·(unknown),(unknown),(unknown),Steven H. Laval,(unknown),P Wordsworth	0
18	The TNFR-I and TNFR-II loci in systemic lupus erythematosus 1997 ·Oxford University Research Archive (ORA) (University of Oxford) ·Joyce Eskdale,Christina M. Armstrong,P Wordsworth,Grant Gallagher	1
19	Susceptibility to ankylosing spondylitis in twins: The role of genes, HLA, and the environment 1997 ·Queensland's institutional digital repository (The University of Queensland) ·Matthew A. Brown,Alex J. MacGregor,(unknown),Chris Darke,Emma L. Duncan,Andrei Călin,(unknown),Andrew Taylor,P Wordsworth	108
20	NO ADDITIONAL ROLE FOR THE MHC CLASS-II ENCODED COMPONENTS OF THE HLA CLASS-I PATHWAY OF ANTIGEN PRESENTATION (LMP2, TAP1-AND-2) IN THE ETIOLOGY OF ANKYLOSING-SPONDYLITIS (AS) 1993 ·Lara D. Veeken ·K Pile,(unknown),Kathryn Gibson,A Călin,(unknown),P. J. Sinnott,Stephen H. Powis,P Wordsworth	3

About P Wordsworth

P Wordsworth is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 91 papers that have together received 3.5k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (36 papers), Systemic Lupus Erythematosus Research (26 papers) and Spondyloarthritis Studies and Treatments (24 papers). The work is most often cited by research in Rheumatology (2.2k citations), Immunology (1.6k citations) and Hematology (530 citations). P Wordsworth has collaborated with scholars based in United Kingdom, India and United States. Frequent co-authors include Jane Worthington, Matthew A. Brown, Anne Barton, James Bell, Stephen Eyre, Andrei Călin, Emma L. Duncan, Chris Darke, Andrew Taylor and Alex J. MacGregor. Their work appears in journals such as Proceedings of the National Academy of Sciences, Circulation and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact